Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D
Conditions
Interventions
4-OH tamoxifen
Placebo
Locations
19
United States
Mesa Obstetricians and Gynecologists/Cactus Clinical Research
Mesa, Arizona, United States
Visions Clinical Research
Tucson, Arizona, United States
United Clinical Research
Beverly Hills, California, United States
City of Hope
Duarte, California, United States
USC-Keck Medical Center
Los Angeles, California, United States
South Florida Medical Research
Aventura, Florida, United States
Start Date
August 21, 2017
Primary Completion Date
January 14, 2019
Completion Date
April 23, 2019
Last Updated
July 26, 2022
Lead Sponsor
BHR Pharma, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions